CXCR3 and breast cancer: (97) examined CXCR3 expression levels in the cytoplasm and cytosol of 75 cancer cells from patients diagnosed with stage I/II breast cancer and found that patients with high CXCR3 expression had shorter overall survival and that CXCR3 expression levels were positively correlated with tumor size, metastasis, or the number of involved lymph nodes, suggesting that high CXCR3 expression is closely associated with poor prognosis in patients with early stage breast cancer.